Product image of Kredex (Carvedilol) supplied by GNH India

Kredex

Active Ingredient:
Carvedilol
Origin:
EU

Kredex (Carvedilol)

Carvedilol, the active ingredient in Kredex, is a beta blocker (non‑selective) with alpha‑1 blocking activity presented as an oral tablet for oral use. It reduces blood pressure and improves cardiac function, and is indicated for the management of hypertension, chronic heart failure, and left ventricular dysfunction in adult patients.

GNH India supplies Kredex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Manufacturer / TM Owner

Cheplapharm Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kredex (carvedilol) is employed in cardiovascular therapy to control blood pressure and improve heart performance.

  • Hypertension: lowers systolic and diastolic pressure, reducing cardiovascular risk.
  • Chronic heart failure: improves left ventricular ejection fraction and decreases hospitalisation rates.
  • Left ventricular dysfunction: enhances myocardial contractility and mitigates symptoms of reduced cardiac output.

How It Works

  • Carvedilol blocks β1, β2, and α1‑adrenergic receptors, leading to decreased heart rate, reduced myocardial contractility, and vasodilation of peripheral vessels. The combined β‑blockade and α1‑blockade lower cardiac output and systemic vascular resistance, thereby lowering arterial pressure and improving cardiac efficiency in heart‑failure states.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Dizziness or light‑headedness.
  • Fatigue or tiredness.
  • Headache.
  • Nausea.
  • Peripheral edema.
  • Hypotension.

Serious or Rare Side Effects

  • Bronchospasm, especially in patients with asthma or COPD.
  • Severe bradycardia or heart block.
  • Worsening heart failure.
  • Hepatic dysfunction or jaundice.
  • Allergic reactions such as rash or angioedema.
  • Cardiogenic shock.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate cardiovascular status and comorbid conditions.

  • Monitor blood pressure: adjust dose if hypotension occurs.
  • Assess cardiac function: regular echocardiography for heart‑failure patients.
  • Use caution in asthma or COPD: β2‑blockade may precipitate bronchospasm.
  • Adjust dose in hepatic impairment: reduced metabolism may increase exposure.
  • Avoid abrupt discontinuation: taper to prevent rebound tachycardia.
  • Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Carvedilol may interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Concomitant use with other β‑blockers: risk of excessive bradycardia and hypotension.
  • Potent CYP2D6 inhibitors (e.g., quinidine, paroxetine): may increase carvedilol plasma levels.
  • Strong vasodilators (e.g., nitroglycerin) combined with high doses: can cause severe hypotension.

Moderate Interactions (Monitor Closely)

  • Diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring.
  • Calcium‑channel blockers (especially verapamil, diltiazem): may increase bradycardia risk.
  • NSAIDs: may blunt antihypertensive efficacy.
  • Antidiabetic agents: carvedilol can mask hypoglycaemia symptoms; monitor glucose closely.

Frequently Asked Questions

Kredex, containing carvedilol, is prescribed for hypertension, chronic heart failure, and left ventricular dysfunction. It helps lower blood pressure, improve heart pumping efficiency, and reduce symptoms associated with reduced cardiac output.

Carvedilol blocks β1, β2, and α1‑adrenergic receptors. β‑blockade slows heart rate and reduces contractility, while α1‑blockade causes vasodilation. Together these actions lower blood pressure and decrease the workload on the heart, improving overall cardiac function.

The dose of Kredex is individualized by the prescribing clinician based on the patient’s condition, response, and tolerance. Dosage adjustments are made according to blood pressure readings, heart‑failure status, and any observed side effects.

Safety data for carvedilol in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Kredex (carvedilol) offers combined β‑blockade and α1‑blockade, providing both heart‑rate reduction and vasodilation. This dual action can be advantageous over selective β‑blockers in patients needing additional blood‑pressure control, though individual response and tolerance vary.

Kredex should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Kredex is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe bradycardia, heart block, bronchospasm in patients with asthma or COPD, worsening heart failure, and rare hepatic injury. Patients should be monitored for these events, especially during dose initiation or escalation.

Kredex is contraindicated in patients with known hypersensitivity to carvedilol, those experiencing severe bronchospasm, uncontrolled heart failure, or second‑ or third‑degree AV block without a pacemaker. It should also be avoided in individuals with severe hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Carvedilol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT